Rizatriptan Tablet, Film Coated
Product Images NDC 50090-7747

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan (NDC 50090-7747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907747)

This text appears to include a product code (6iba-o) for a substance named BENZOATE, USP containing 16 MG of an unspecified ingredient. The text also includes additional alphanumeric codes (18, z09507) and the name "RatRipTaN."*

FDA Label Image

Fig-5 (Rizatriptan Fct Figure 5)

FDA Label Image

1 (Rizatriptan Figure One)

This is a table displaying the estimated probability of response for a placebo, Rizatriptan Benzoate Tablets 5 mg, and Rizatriptan Benzoate Tablets 10 mg at 5 and 10 hours post-dose. This information is likely related to the effectiveness of these medications in providing a response within a certain time frame.*

FDA Label Image

1 (Rizatriptan Figure Two)

This data shows the estimated probability of needing additional medication or rescue after taking Placebo, Rizatriptan Benzoate Tablets 5 mg, and Rizatriptan Benzoate Tablets 10 mg at different time intervals post-dose. This information can be valuable for assessing the effectiveness of these medications in managing certain conditions.*

FDA Label Image

1 (Rizatriptan Structure One)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.